Published : 19 November, 2024
Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC), in collaboration with the Association of Physicians of India (API), Rohtak, organized a Continuing Medical Education (CME) program on November 16 to raise awareness about chronic leukemias, including chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL). Dr. Narendra Agrawal from RGCIRC highlighted that these slow-growing blood cancers often go undetected until routine tests reveal abnormalities, with symptoms like fatigue or splenomegaly. The program emphasized the significance of early detection and targeted therapies, such as Imatinib and Dasatinib, which have transformed CML into a manageable condition.
As a society, RGCIRC is looking forward to get support from generous people
Read More
It is a fact that there are absolutely no substitutes to replace human bloo...
Read More
Volunteers play an important role in today’s hospitals. They help the hos...
Read MoreRajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.
D - 18, Sector - 5, Rohini, Delhi - 110085 | +91-11-47022222 OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday) Emergency Services: 24x7 All weekdays
Mahendra Kumar Jain Marg, Niti Bagh, New Delhi - 110049 | Tel: +91-11-45822222 / 2200 OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday) Emergency Services: 24x7 All Weekdays
DONATE